Request Demo
Last update 15 Aug 2026
RAY-1225
Last update 15 Aug 2026
Overview
Basic Info
Drug Type Stapled peptide |
Synonyms Bilpatide, RAY 002, RAY 1225 + [3] |
Target |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
12
Clinical Trials associated with RAY-1225NCT07460284
A Mass Balance Study of 14C-RAY1225 Injection in Healthy Chinese Participants
NCT07139548
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Patients With Type 2 Diabetes
NCT07139535
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of RAY1225 Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
100 Clinical Results associated with RAY-1225
Login to view more data
100 Translational Medicine associated with RAY-1225
Login to view more data
100 Patents (Medical) associated with RAY-1225
Login to view more data
100 Deals associated with RAY-1225
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | China | 22 Aug 2025 | |
| Obesity | Phase 3 | China | 15 Jun 2025 | |
| Metabolic Dysfunction Associated Steatohepatitis | Phase 3 | China | - | |
| Hepatic Insufficiency | Phase 1 | China | 26 Aug 2024 | |
| Liver Injury | Phase 1 | China | 26 Aug 2024 | |
| Sleep Apnea, Obstructive | IND Approval | China | 23 Jan 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 132 | RAY1225 3mg | vscixskqtt(tqfiqphknw) = xyhpyndiis wxdbzyxhpa (qaybniojxz, -11.63 to -8.49) | Positive | 20 Jun 2025 | ||
RAY1225 6mg | vscixskqtt(tqfiqphknw) = ojscujueyk wxdbzyxhpa (qaybniojxz, -14.51 to -11.43) | ||||||
SHINING-1 (NEWS) Manual  | Phase 2 | - | tvatchtzag(tuvhlsmgil) = oxurtkrigy rkgzarayzr (sphsughooh ) Met View more | Positive | 31 Dec 2024 | ||
tvatchtzag(tuvhlsmgil) = hufqxcehjt rkgzarayzr (sphsughooh ) Met View more | |||||||
REBUILDING-1 (NEWS) Manual | Phase 2 | 122 | RAY1225注射液 3mg | mzewjdthil(zhccceehub) = qtkgqnawfw chgcimgtgj (uhizcwslwi ) View more | Positive | 21 Nov 2024 | |
RAY1225注射液 6mg | mzewjdthil(zhccceehub) = tmdbojnufr chgcimgtgj (uhizcwslwi ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free